| Literature DB >> 5251696 |
K Hellmann, K A Newton, D N Whitmore, I W Hanham, J V Bond.
Abstract
I.C.R.F. 159, a new antitumour agent, has been assessed in six patients with acute leukaemia and three with lymphosarcoma. In all but two there was a considerable fall in circulating primitive cells, and in one there was bone-marrow evidence of a partial remission. Severe toxic effects were seen in only one case; they consisted of alopecia and gastroenteritis. It is suggested that I.C.R.F. 159 is worth further examination in all forms of acute leukaemia and lymphosarcoma.Entities:
Mesh：
Substances：
Year: 1969 PMID： 5251696 PMCID： PMC1982474 DOI： 10.1136/bmj.1.5647.822
Source DB: PubMed Journal: Br Med J ISSN： 0007-1447